Buy Like Buffett
Watchlist

Flagship explainer

What drives NeuroOne Medical Technologies Corporation’s return on equity?

ROE is five filed business factors multiplied together.

DuPont return on equity factor treeReturn on equity branches into tax burden, interest burden, operating margin, asset turnover, and the equity multiplier.Return on equity−91%Tax burden100%net income ÷ pretax incomeInterest burden85%pretax ÷ operating incomeOperating margin−46%operating income ÷ revenueAsset turnover1.13×revenue ÷ average assetsEquity multiplier2.05×average assets ÷ average equityAs of 2025-09-30 · 1 SEC filing sourceBuy Like Buffett · buylikebuffett.com
DuPont source inputs
InputValueFiscal yearSource
−$3.6MFY2025
  • 10-K · FY 2025Filing detailsAccession 0001213900-25-122390 · filed Dec 17, 2025
Income before tax−$3.6MFY2025
  • 10-K · FY 2025Filing detailsAccession 0001213900-25-122390 · filed Dec 17, 2025
Operating income−$4.2MFY2025
  • 10-K · FY 2025Filing detailsAccession 0001213900-25-122390 · filed Dec 17, 2025
$9.1MFY2025
  • 10-K · FY 2025Filing detailsAccession 0001213900-25-122390 · filed Dec 17, 2025
Ending assets$10.8MFY2025
  • 10-K · FY 2025Filing detailsAccession 0001213900-25-122390 · filed Dec 17, 2025
Beginning assets$5.4MFY2024
  • 10-K · FY 2024Filing detailsAccession 0001213900-25-122390 · filed Dec 17, 2025
$7.1MFY2025
  • 10-K · FY 2025Filing detailsAccession 0001213900-25-122390 · filed Dec 17, 2025
$822013FY2024
  • 10-K · FY 2024Filing detailsAccession 0001213900-25-122390 · filed Dec 17, 2025
Source: · event Sep 30, 2025 · retrieved Oct 16, 2026 · annual-row source set
Embed this chart

View the full NeuroOne Medical Technologies Corporation analysis at Buy Like Buffett